Pfizer Ltd. — Regulatory Filings 2022

Apr 7, 2022

Pfizer Limited

==> picture [100 x 41] intentionally omitted <==

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

April 7, 2022

The Corporate Relationship Dept. BSE Limited[st] Floor, P.J.Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Pfizer Limited - Non-Applicability of Initial/Annual Disclosure to be made by an

entity identified as a Large Corporate.

I, Prajeet Nair, Company Secretary of Pfizer Limited (“Company”) hereby confirm that, the Company has no borrowings as on March 31, 2022 and does not fall under the category of Large Corporate as per the SEBI circular dated November 26, 2018 bearing number SEBI/HO/DDHS/CIR/P/2018/144. Accordingly, the requirement for submission of Initial / Annual disclosure under the said Circular is not applicable to the Company

We request you to kindly take the same on record.

Thanking you,

Yours truly,

For Pfizer Limited

==> picture [111 x 55] intentionally omitted <==

Prajeet Nair Company Secretary

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerindia.com